Skip to main content
CIZZLE BIOTECHNOLOGY HOLDINGS PLC logo

CIZZLE BIOTECHNOLOGY HOLDINGS PLC — Investor Relations & Filings

Ticker · CIZ ISIN · GB00BNG2VN02 LEI · 213800G3OS3SA2J1Y358 IL Professional, scientific and technical activities
Open in API
Filings indexed 329 across all filing types
Latest filing 2025-08-18 Regulatory Filings
Country GB United Kingdom
Listing IL CIZ

About CIZZLE BIOTECHNOLOGY HOLDINGS PLC

https://cizzlebiotechnology.com/

Cizzle Biotechnology Holdings PLC is a cancer diagnostics developer focused on the early detection of lung cancer. The company is advancing a non-invasive, cost-effective blood test designed to identify lung cancer at its earliest stages, often before symptoms appear. The test utilizes a proprietary CIZ1B biomarker and an advanced immunoassay. Its primary goal is to improve patient outcomes by enabling swift, curative medical intervention. The technology aims to streamline the diagnostic pathway, reduce reliance on CT scans which can have high false-positive rates, and eliminate unnecessary invasive follow-up procedures. The company, a spin-out from the University of York, is conducting clinical trials to support global regulatory approval and adoption of its technology.

Recent filings

Filing Released Lang Actions
Commercial Progress in USA
Regulatory Filings Classification · 100% confidence The document is an official announcement distributed via the London Stock Exchange's RNS (Regulatory News Service). It details commercial progress, specifically a new licensing agreement and a revised royalty payment schedule for Cizzle Biotechnology Holdings PLC. Since it is a general regulatory announcement regarding business operations and financing updates that does not fit into more specific categories like 10-K, ER, or M&A, it is classified as a Regulatory Filing (RNS).
2025-08-18 English
Annual Report for the year ended 31 December 2024
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual Report for the year ended 31 December 2024'. It contains comprehensive sections including company information, directors, chair's statement, product development, clinical evaluation, and funding details. It is a full-length report rather than an announcement or a summary, fitting the definition of an Annual Report (10-K). FY 2024
2025-07-08 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement from Cizzle Biotechnology Holdings PLC regarding the 'Result of AGM'. It provides a detailed table of proxy votes cast for various resolutions during the Annual General Meeting. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2025-06-30 English
Group of companies' accounts made up to 2024-12-31
Regulatory Filings
2025-06-09 English
Notice of AGM
Report Publication Announcement Classification · 99% confidence The document is titled 'Notice of Annual General Meeting and Posting of Annual Report'. It explicitly states that the 'notice of Annual General Meeting ("AGM") will be posted to shareholders today, along with the Company's Annual Report and Financial Statements for the year ended 31 December 2024'. Since the document's primary function is to announce the posting/availability of the AGM notice and the Annual Report, and given its very short length (3178 chars), it fits the definition of a Report Publication Announcement (RPA) rather than being the full Annual Report (10-K) or the AGM materials (AGM-R) themselves. It is an announcement about the publication of reports.
2025-06-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields related to changes in voting rights, shareholder details, and thresholds crossed. This form is a standard regulatory filing used in the UK/EU to report significant changes in share ownership. The presence of 'RNS Number', 'FCA' (Financial Conduct Authority), and the structure strongly indicate a regulatory disclosure concerning shareholdings. This aligns best with the 'Major Shareholding Notification' category (MRQ), as it details a change in ownership crossing a notification threshold (11.14% vs previous 10.01%). Although RNS is mentioned, the content is a specific regulatory form, making MRQ more precise than the general RNS fallback.
2025-05-28 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.